Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$878.7M
Avg Funding
$35.1M
Global Reach
9
countries

Top Cities for Biopharma

Doylestown
San Diego
Leuven
Leiden
Cambridge
Lewes

Recently Funded Companies

Export
Doylestown, United States

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

$89.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

$400K raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Leuven, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

$83.9M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Leiden, The Netherlands

EXIT071 is a Netherlands-based startup developing advanced technologies for extracellular vesicle (EV) isolation and analysis.

$2.1M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Mar 2026

Founder Contacts

30,000+ verified contacts

Lewes, United States

Halcyon Wellness is a biotechnology company that offers bioengineered liver health and wellness services.

$8.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Roscoff, France

Perha Pharmaceuticals is a bio technology company which does research & development of kinase inhibitors.

$2.8M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

$123.0M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Hayward, United States

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

$67.0M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Transforming chronic wound care with breakthrough enzymatic technology

$518K raised
Mar 2024

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Consone AI a disruptive technology platform targeting decisions that are made in the drug development process.

$256K raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Mar 2023

Founder Contacts

30,000+ verified contacts

Lyon, France

Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.

$2.7M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

$75.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Mount Waverley, Australia

Cann Group is a developer and supplier of cannabis, cannabis resin and medicinal cannabis products into the market.

$533K raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

$73.9M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

$16.1M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

New York, United States

Ovid Therapeutic's purpose is to solve intractable medical problems.

$60.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Bothell, United States

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

$110.0M raised
Mar 2025

Founder Contacts

30,000+ verified contacts

Excelsior, United States

Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).

$1.6M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Los Altos, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

$120.0M raised
Mar 2026

Founder Contacts

30,000+ verified contacts

Copenhagen, Denmark

MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.

Mar 2023

Founder Contacts

30,000+ verified contacts

Torino, Italy

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

$20.4M raised
Mar 2022

Founder Contacts

30,000+ verified contacts

Paris, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

$8.7M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Barcelona, Spain

Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.

$12.9M raised
Mar 2023

Founder Contacts

30,000+ verified contacts

Showing 351 to 375 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$35.1M
Total Funding Tracked
$878.7M
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
5 companies$197.4M
2.San Diego
2 companies$16.5M
3.Doylestown
1 companies$89.0M
4.Leuven
1 companies$83.9M
5.Leiden
1 companies$2.1M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 15 | VCBacked